Skip to main navigation Skip to search Skip to main content

Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation

  • Tiina Mustonen
  • , Ilkka Rauma
  • , Päivi Hartikainen
  • , Johanna Krüger
  • , Marja Niiranen
  • , Tuomas Selander
  • , Sakari Simula
  • , Anne M. Remes.
  • , Hanna Kuusisto

    Research output: Contribution to journalArticleScientificpeer-review

    16 Citations (Scopus)
    Original languageEnglish
    Article number101498
    Pages (from-to)101498
    JournalMultiple Sclerosis and Related Disorders
    Volume38
    DOIs
    Publication statusPublished - 2020
    Publication typeA1 Journal article-refereed

    Keywords

    • Discontinuation
    • Multiple sclerosis
    • Natalizumab
    • Reactivation
    • Rebound

    Publication forum classification

    • Publication forum level 1

    Cite this